ClinicalTrials HQ

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Recruiting · NCT04685616 · Registry updated 2026-07-08
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Brentuximab Vedotin in Early Stage Hodgkin LymphomaHemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 32026-07-08NCT04685616

7 results · Page 1 of 1

72 results · Page 1 of 3

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aarhus University Hospitak SkjebyAarhusDenmark1
Aberdeen Royal InfirmaryAberdeenUnited Kingdom21
Amsterdam UMC - Location vUmcAmsterdamNetherlands2
Auckland City HospitalAucklandNew Zealand68
AZ Delta Campus RumbekeRoeselareBelgium1
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom39
Blackpool Victoria HospitalBlackpoolUnited Kingdom4
Box Hill HospitalBox HillAustralia1
Bristol Haematology and Oncology CentreBristolUnited Kingdom9
CancerCare ManitobaWinnipegCanada2
Castle Hill HospitalHullUnited Kingdom6
Christie HospitalManchesterUnited Kingdom12
CHU-UCL NamurNamurBelgium2
Churchill HospitalOxfordUnited Kingdom43
Colchester Hospital, ESNEFTColchesterUnited Kingdom1
Complejo Hospitalario de NavarraPamplonaSpain8
Concord Repatriation General HospitalSydneyAustralia1
Derriford HospitalPlymouthUnited Kingdom37
Freeman Hospital, NewcastleNewcastle upon TyneUnited Kingdom1
Glan Clwyd HospitalBodelwyddanUnited Kingdom4
Hampshire Hospitals NHS Foundation TrustBasingstokeUnited Kingdom4
Hospital Del MarBarcelonaSpain1
Institut Catala d'OncologiaBarcelonaSpain1
Instituto Portugues de Oncologia de Lisboa Francisco GentilLisbonPortugal1
Juravinski Cancer CentreHamiltonCanada24